- Home
- »
- Biotechnology
- »
-
Protein Sequencing Market Size, Share Report, 2026-2033GVR Report cover
Protein Sequencing Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product & Service (Protein Sequencing Products, Protein Sequencing Services), By Application, By End Use, By Region And Segment Forecasts
Market Size, 2025
$1.5BMarket Estimate, 2026
$1.6BMarket Forecast, 2033
$2.0BCAGR, 2026–2033
3.7%Protein Sequencing Market Summary
The global protein sequencing market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 2.0 billion by 2033, at a CAGR of 3.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. This growth is attributed to advancements in proteomics research and increasing funding for R&D activities.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product & services: The protein sequencing products segment held the largest market share of around 80.0% in 2025.
- By applications: The biotherapeutics segment held the largest market share in 2025.
- By end use: The academic institutes & research centers segment held the largest market share of over 45.0% in 2025.
Regional Highlights
- Largest regional market: North America (35.0% revenue share, 2025)
Market Size & Forecast
- Market size in 2025: USD 1.5 Billion
- Estimated market size in 2026: USD 1.6 Billion
- Projected market size by 2033: USD 2.0 Billion
- CAGR (2026-2033): 3.7%
Prism AI by Grand View Research Free to tryAsk a question about the protein sequencing marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →In addition, the rising adoption of mass spectrometry for protein sequencing and the development of integrated, automated sequencing systems by key players are fueling market expansion. Furthermore, the increasing emphasis by pharmaceutical and biotechnology firms on target-based drug development, particularly in developed and emerging countries, is another significant driver of the market.
Protein sequencing is identifying the exact order of amino acids that make up a protein or peptide. This technique allows researchers to determine the identity of a protein and identify any modifications it has undergone after translation. In many cases, only a small portion of the protein's sequence (known as sequence tags) is needed to match it to a database of protein sequences derived from gene sequences. The two main direct methods for protein sequencing are Edman degradation and mass spectrometry using an automated sequencing instrument.
In addition, increased funding for proteomics research from the public and private sectors is enhancing research capabilities, especially in emerging economies. Furthermore, pharmaceutical companies' growing focus on target-based drug development is increasing the application of protein sequencing in biotherapeutics and genetic engineering. Technological advancements in mass spectrometry and integrated sequencing systems lead to more effective and precise sequencing approaches.
Moreover, the growing demand for personalized medicine and the identification of disease biomarkers further boost the market growth. Partnerships among academic institutions and biotech firms to develop innovative sequencing techniques are expected to foster new revenue streams. Overall, sustained investment in R&D and the expansion of applications across various sectors will significantly drive the market growth in the coming years.
Analyst Perspective
The global protein sequencing industry is experiencing strong growth, fueled by increased investment in proteomics research and biopharmaceutical development, as well as advances in sequencing technologies. Protein sequencing products lead the market, driven by high demand for instruments, reagents, and consumables in research and drug discovery. Adoption of protein sequencing for biotherapeutic characterization, biomarker discovery, and personalized medicine is further expanding the market. Continued innovation in sequencing platforms and greater collaboration between technology providers and research organizations are expected to accelerate growth throughout the forecast period.
Product & Services Insights
The protein sequencing products segment led the market with the largest revenue share of around 80.0% in 2025, attributed to the rising adoption of techniques, such as mass spectrometry and Edman degradation technologies, by academic institutions, pharmaceutical companies, and biotechnology firms for applications such as biotherapeutics characterization, proteomics research, and drug discovery, which is fueling demand for sequencing instruments, reagents, and consumables. In addition, growing investment in proteomics R&D, especially in developed regions such as North America and Europe, provides funding for sequencing product purchases.
Protein sequencing products are categorized into various segments, such as reagents and consumables, instruments, and software. Reagents and consumables dominated the market, accounting for the largest revenue share in 2025, owing to advancements in proteomics research and increased demand for accurate protein analysis. Furthermore, the growing complexity of protein sequencing techniques also necessitates a wider range of specialized reagents, further propelling market growth in this segment.
The protein sequencing services segment is expected to grow at a significant CAGR over the forecast period, driven by the increasing complexity of protein analysis and the high costs associated with sequencing infrastructure. In addition, technological advancements, such as mass spectrometry and next-generation sequencing, have enhanced service offerings. Furthermore, the rising demand for personalized medicine and biomarker discovery further fuels this growth as pharmaceutical and biotechnology companies seek efficient drug development and proteomic research solutions.
Applications Insights
The biotherapeutics segment accounted for the largest market revenue share in 2025, attributed to the increasing focus of pharmaceutical companies on developing innovative biotherapeutics, particularly monoclonal antibodies. These therapeutic proteins are important for treating numerous diseases, including cancer and autoimmune disorders. Furthermore, developments in protein sequencing technologies enhance the characterization and quality control of biopharmaceuticals. For instance, in February 2025, Northwestern University researchers demonstrated that combining Quantum-Si's Next-Generation Protein Sequencing with individual ion mass spectrometry enables detailed analysis of interleukin 6. The growing demand for personalized medicine further propels this segment, as precise protein sequencing is crucial for recognizing biomarkers and modifying treatments to individual patient needs, thereby supporting the market growth.
The genetic engineering segment is expected to grow at the fastest CAGR over the forecast period, owing to increasing investments in biotechnology and pharmaceutical research, enhancing the need for precise protein characterization. In addition, the demand for genetically engineered proteins in therapeutic applications, such as monoclonal antibodies and vaccines, further drives this growth. Furthermore, the rise of personalized medicine demands accurate protein sequencing to tailor treatments based on individual genetic needs.
End Use Insights
The academic institutes & research centers segment led the market with the largest revenue share of over 45.0% in 2025, driven by increasing funding for proteomics research from public and private entities. These institutions are engaged in extensive biological and biomedical studies that require advanced protein sequencing technologies to identify and characterize proteins. The growing demand for protein analysis across disciplines such as molecular biology and pharmacology further drives this segment.
The pharmaceutical & biotechnology segment is expected to grow at the fastest CAGR over the forecast period, driven by the increasing focus of major pharmaceutical and biotechnology businesses on target-based drug development, particularly in developed and emerging economies. The growing demand for protein sequencing in numerous applications, such as biotherapeutics characterization, drug discovery, and disease biomarker identification, further drives this segment. Furthermore, the increasing investment by pharmaceutical and biotech companies in proteomics R&D, along with the need for protein sequencing in biopharmaceutical quality control, supports the segment's expansion.
Regional Insights
North America dominated the global protein sequencing market with the largest revenue share of approximately 35.0% in 2025. The region benefits from advanced technological innovations and a robust healthcare infrastructure, which facilitates extensive research and development in proteomics. In addition, substantial funding from government and private organizations supports ongoing research initiatives. Furthermore, the presence of key industry players, such as Quantum-Si, which is launching cutting-edge protein sequencing systems, enhances market dynamics. For instance, in November 2024, Quantum-Si and Avantor signed a distribution agreement to expand access to Quantum-Si’s Next-Generation Protein Sequencing (NGPS) portfolio in the U.S. and Canada, thereby increasing the availability of advanced protein sequencing technologies. These developments position North America as a leader in this field over the forecast period.
To learn more about this report,Download Free Sample Report
U.S. Protein Sequencing Market Trends
The protein sequencing market in the U.S. accounted for the largest market revenue share in North America in 2025, owing to a strong emphasis on target-based drug development and increasing investments in biotechnology research. The U.S. is home to numerous leading academic institutions and research centers that contribute to advancements in protein sequencing technology. Moreover, federal funding for biomedical research significantly bolsters the market, enabling innovative studies and applications in drug discovery and personalized medicine. This combination of factors positions the U.S. as a pivotal market for growth in protein sequencing.
Asia Pacific Protein Sequencing Market Trends
The protein sequencing market in the Asia Pacific is expected to grow at a significant CAGR over the forecast period. This growth is attributed to increasing investments in biotechnology and pharmaceutical research. Countries such as India and China are emerging as significant hubs for proteomics, driven by rising demand for personalized medicine and biomarker discovery. Furthermore, the growing number of academic initiatives focused on developing protein-based therapeutics enhances research capabilities and fosters collaborations, collectively contributing to the region's expanding market opportunities.
The China protein sequencing market is expected to grow substantially over the forecast period, fueled by government support for scientific research and innovation. The country is witnessing a surge in biotechnology firms focused on drug discovery and development that heavily rely on protein sequencing technologies. Furthermore, advancements in mass spectrometry and other sequencing methods are improving the accuracy and efficiency of protein analysis. The increased emphasis on developing novel therapeutics and diagnostics further propels the demand for protein sequencing services and products in the Chinese market.
Europe Protein Sequencing Market Trends
The protein sequencing market in Europe accounted for a significant revenue share in 2025, driven by increased funding for life sciences research and a strong emphasis on personalized medicine. European countries are investing heavily in proteomics and biotechnology, which enhances the demand for accurate protein sequencing technologies. Numerous academic institutions and research centers are conducting extensive studies in drug development and biomarker discovery, further driving this growth. In addition, the rising adoption of advanced sequencing methods, such as mass spectrometry, supports the market's expansion across the region.
Key Protein Sequencing Company Insights
Some key companies in the protein sequencing industry include Thermo Fisher Scientific, Inc., Shimadzu Corporation, Agilent Technologies, and others. These companies are adopting various strategies, such as investing in research and development to innovate advanced sequencing technologies and enhance accuracy and throughput to gain a competitive edge.
In addition, strategic collaborations and partnerships with academic institutions and biotechnology firms are also common, facilitating knowledge exchange and resource sharing. Furthermore, companies focus on expanding their product portfolios through new product launches and acquisitions, addressing diverse customer needs, and strengthening their market presence.
Key Protein Sequencing Companies
The following key companies have been profiled for this study on the global protein sequencing market:
-
Thermo Fisher Scientific, Inc.
-
Shimadzu Corporation
-
Agilent Technologies, Inc.
-
Rapid Novor, Inc.
-
Proteome Factory AG
-
Selvita
-
Bioinformatics Solutions Inc.
-
Creative Proteomics
-
Alphalyse
-
Quantum-Si Incorporated
Recent Developments
-
In September 2025, Quantum-Si launched the V4 Sequencing Kit for its Platinum and Platinum Pro protein sequencing platforms. This kit expands proteome coverage, enhances amino acid recognition, and supports applications such as antibody sequencing.
-
In November 2024, Quantum-Si formed a strategic collaboration with NVIDIA to accelerate development of its next-generation protein sequencing platform, Proteus. By leveraging NVIDIA's AI and accelerated computing, the partnership aims to improve data processing and advance Quantum-Si's sequencing technologies, thereby enabling faster, more scalable single-molecule protein sequencing workflows.
Protein Sequencing Market Report Scope
Report Attribute
Details
Market size in 2025
USD 1.5 billion
Estimated market size in 2026
USD 1.6 billion
Projected market size by 2033
USD 2.0 billion
Growth rate
CAGR of 3.7% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 – 2024
Forecast period
2026 – 2033
Quantitative units
Revenue in USD million/billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product & services, application, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; Russia; China; Japan; India; Thailand; South Korea; Brazil; Saudi Arabia;UAE; Kuwait
Key companies profiled
Thermo Fisher Scientific, Inc.; Shimadzu Corporation; Agilent Technologies, Inc.; Rapid Novor, Inc.; Proteome Factory AG; Selvita; Bioinformatics Solutions Inc.; Creative Proteomics; Alphalyse; Quantum-Si Incorporated
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Protein Sequencing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global protein sequencing market report based on product & service, application, end use, and region:
-
Product & Service Outlook (Revenue, USD Billion, 2021 - 2033)
-
Protein Sequencing Products
-
Reagents & Consumables
-
Instruments
-
Software
-
Protein Sequencing Services
-
-
Application Outlook (Revenue, USD Billion, 2021 - 2033)
-
Bio-therapeutics
-
Genetic Engineering
-
Others
-
-
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
-
Academic Institutes & Research Centers
-
Pharmaceutical & Biotechnology Companies
-
Others
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The global protein sequencing market size was valued at USD 1.5 billion in 2025 and is estimated at USD 1.6 billion for 2026.
The global protein sequencing market is expected to grow at a CAGR of 3.7% from 2026 to 2033, reaching USD 2.0 billion by 2033.
North America dominated with a 35.0% revenue share in 2025.
Some key players operating in the protein sequencing market include Thermo Fisher Scientific, Inc., Shimadzu Corporation, Agilent Technologies, Inc., Rapid Novor, Inc., Proteome Factory AG, Selvita, Bioinformatics Solutions Inc., Creative Proteomics, Alphalyse, Quantum-Si Incorporated, and others.
The protein sequencing products segment accounted for the largest revenue share of approximately 80.0% in 2025.
About the Author(s)
Biotechnology Research Team
Healthcare · BiotechnologyThis report was authored by the biotechnology research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the biotechnology segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.